fungal infection – Page 3

Photo Quiz: Asteroid bodies in a skin biopsy of a farmer

mycolabadmin

A farmer developed a chain of red nodules on his arm after a wrist injury, which was diagnosed as sporotrichosis, a fungal infection caused by Sporothrix globosa. The diagnosis was confirmed through tissue biopsy, which showed distinctive asteroid bodies – yeast cells surrounded by radiating material that represents the body’s immune response. The infection was successfully treated with oral potassium iodide over 6 months, resulting in complete healing.

Aspergillus Bronchitis at Localised Mucus Plug in an Immunocompetent Patient

mycolabadmin

A 55-year-old woman developed a rare fungal infection called Aspergillus bronchitis in a mucus plug within her lung over a 9-year period. Although she was otherwise healthy with a normal immune system, the fungus gradually grew and eventually caused serious bleeding in her lungs. Doctors treated the bleeding with artery embolization and then surgically removed the affected lung tissue. The fungus was identified as Aspergillus udagawae, a type that is harder to treat with standard antifungal medications.

Deep cutaneous fungal infection in an immunocompetent individual caused by a biological pesticide: a rare case report

mycolabadmin

A 66-year-old farmer developed recurring skin infections over 10 years from exposure to a biological pesticide containing a fungus called Purpureocillium lilacinum. Although this fungus is generally safe for healthy people, this case shows it can cause serious skin infections with prolonged exposure. The patient was successfully treated with antifungal medication over three months. This case highlights the importance of proper safety measures when working with biological pesticides.

Disseminated subcutaneous sporotrichosis in an immunocompetent patient: A case report and a systematic literature review

mycolabadmin

A 74-year-old man developed painful red masses on his arm and hand after being stuck by a tree branch. Tests identified the infection was caused by a fungus called Sporothrix schenckii. Despite having a normal immune system, the infection had spread across his arm in an unusual pattern. Treatment with an antifungal medication called itraconazole completely healed the lesions within four months without any scarring.

Condition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on Aspergillus fumigatus growth

mycolabadmin

This study examines how Trikafta, a new cystic fibrosis medication, affects a common fungal lung infection (Aspergillus fumigatus). The researchers found that Trikafta doesn’t directly kill the fungus but does make it more susceptible to antifungal drugs and improves lung clearance. Surprisingly, at high concentrations, the medication actually reduced the immune response against the fungus in immune cells, suggesting the need for careful monitoring of patients on this therapy.

PTP1B deficiency in myeloid cells increases susceptibility to Candida albicans systemic infection by modulating antifungal immunity

mycolabadmin

This research shows that a protein called PTP1B plays an important role in protecting the body against dangerous yeast infections caused by Candida albicans. When this protein is missing from immune cells, mice become much more susceptible to severe fungal infections. The study found that PTP1B helps immune cells called macrophages and neutrophils kill fungi effectively, and when it’s absent, these immune cells work poorly. This discovery suggests that targeting PTP1B could be a new way to help patients fight off serious fungal infections.

Extensive and recurrent infection caused by Medicopsis romeroi in two immunocompromised patients

mycolabadmin

This case report describes two patients with weakened immune systems who developed serious fungal skin infections caused by a rare mold called Medicopsis romeroi. Both patients underwent multiple surgeries and required extended antifungal medication treatment lasting months to years. The study demonstrates that successful treatment requires a combination approach including surgical removal of infected tissue, adjustment of immunosuppressive medications, and prolonged antifungal therapy.

Phaeoacremonium tuscanicum and Phaeoacremonium indicum sp. nov. associated with subcutaneous phaeohyphomycosis

mycolabadmin

Researchers identified two cases of rare fungal skin infections caused by Phaeoacremonium species. One case involved a new fungal species named Phaeoacremonium indicum discovered in an Indian patient, while the second case from Australia represented the first documented human infection with P. tuscanicum. Both patients were successfully treated through surgical removal of the infected tissue, though one patient was immunocompromised from a kidney transplant. This study highlights how genetic testing helps identify rare fungal species that cause human infections.

Extensive erythematous plaques of fungal origin in an overseas student: Cutaneous manifestation of coccidioidomycosis

mycolabadmin

A 21-year-old student studying in Arizona developed unusual skin rashes months after returning to China. Doctors had difficulty diagnosing the condition because it lacked typical symptoms of the fungal infection coccidioidomycosis. By using multiple diagnostic methods including DNA sequencing and fungal culture, they identified the infection as caused by Coccidioides posadasii. When the initial antifungal drug didn’t work, testing showed the fungus was resistant, so they switched to a different antifungal called voriconazole, which successfully cured the infection after 12 months.

Infection caused by a cryptic fungal species, Blastomyces gilchristii, in a tiger

mycolabadmin

A tiger in Tennessee became ill with a serious fungal infection caused by a lesser-known fungus called Blastomyces gilchristii. While blastomycosis is typically caused by a different fungus species, this case represents the first detection of this particular cryptic fungal species in the southeastern United States. Scientists used advanced genetic sequencing to identify the fungus when standard laboratory methods failed. This discovery suggests that this dangerous fungus is spreading to areas where it was not previously thought to exist.

Research Topic: fungal infection